Free Trial

GRAIL (GRAL) Competitors

GRAIL logo
$32.18 -1.80 (-5.30%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$32.40 +0.22 (+0.68%)
As of 08/14/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GRAL vs. OPCH, RDNT, BTSG, SHC, WGS, SGRY, CON, PRVA, ADUS, and PGNY

Should you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), GeneDx (WGS), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Addus HomeCare (ADUS), and Progyny (PGNY). These companies are all part of the "healthcare" industry.

GRAIL vs. Its Competitors

GRAIL (NASDAQ:GRAL) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

GRAIL has a beta of 3.26, indicating that its share price is 226% more volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500.

Option Care Health has higher revenue and earnings than GRAIL. GRAIL is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GRAIL$125.60M9.22-$2.03B-$13.11-2.45
Option Care Health$5.00B0.92$211.82M$1.2522.73

Option Care Health has a net margin of 3.93% compared to GRAIL's net margin of -329.86%. Option Care Health's return on equity of 17.53% beat GRAIL's return on equity.

Company Net Margins Return on Equity Return on Assets
GRAIL-329.86% -16.32% -13.69%
Option Care Health 3.93%17.53%7.17%

98.1% of Option Care Health shares are owned by institutional investors. 1.9% of GRAIL shares are owned by company insiders. Comparatively, 0.6% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

GRAIL presently has a consensus price target of $31.50, suggesting a potential downside of 2.11%. Option Care Health has a consensus price target of $35.75, suggesting a potential upside of 25.84%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts clearly believe Option Care Health is more favorable than GRAIL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GRAIL
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
Option Care Health
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

In the previous week, GRAIL had 7 more articles in the media than Option Care Health. MarketBeat recorded 18 mentions for GRAIL and 11 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.69 beat GRAIL's score of 0.25 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GRAIL
4 Very Positive mention(s)
4 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral
Option Care Health
9 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Option Care Health beats GRAIL on 12 of the 16 factors compared between the two stocks.

Get GRAIL News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRAL vs. The Competition

MetricGRAILMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.22B$3.10B$5.61B$9.84B
Dividend YieldN/A2.23%4.61%4.07%
P/E Ratio-2.4520.4930.2925.74
Price / Sales9.22356.37463.41115.83
Price / Cash1.1843.0338.2159.48
Price / Book0.438.608.826.15
Net Income-$2.03B-$54.65M$3.25B$265.06M
7 Day Performance-1.95%5.86%3.70%2.60%
1 Month Performance-16.48%8.86%5.84%2.83%
1 Year Performance102.77%13.33%29.92%25.58%

GRAIL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRAL
GRAIL
1.0838 of 5 stars
$32.18
-5.3%
$31.50
-2.1%
+109.1%$1.22B$125.60M-2.451,360News Coverage
Earnings Report
OPCH
Option Care Health
4.7078 of 5 stars
$28.26
flat
$35.75
+26.5%
-7.3%$4.59B$5.00B22.618,088Positive News
RDNT
RadNet
3.3208 of 5 stars
$55.77
+2.0%
$69.60
+24.8%
+9.8%$4.10B$1.83B-129.6911,021News Coverage
Earnings Report
Analyst Upgrade
Analyst Revision
BTSG
BrightSpring Health Services
2.6841 of 5 stars
$19.36
-1.4%
$24.90
+28.6%
+93.2%$3.45B$11.27B62.4535,000
SHC
Sotera Health
1.2086 of 5 stars
$11.28
+1.2%
$16.00
+41.8%
+7.1%$3.16B$1.10B141.023,000Earnings Report
WGS
GeneDx
1.9589 of 5 stars
$108.35
+6.6%
$101.63
-6.2%
+263.2%$2.90B$362.32M2,167.001,200Gap Down
SGRY
Surgery Partners
2.9283 of 5 stars
$22.22
+4.4%
$33.33
+50.0%
-22.8%$2.73B$3.11B-14.5215,000
CON
Concentra Group Holdings Parent
2.1864 of 5 stars
$19.79
+1.6%
$28.50
+44.0%
+1.6%$2.50B$1.90B14.7711,250Dividend Announcement
PRVA
Privia Health Group
3.4227 of 5 stars
$19.47
+3.2%
$28.38
+45.8%
+7.4%$2.30B$1.74B162.261,140Earnings Report
Analyst Forecast
ADUS
Addus HomeCare
4.9449 of 5 stars
$106.96
+1.9%
$142.57
+33.3%
-11.1%$1.93B$1.15B24.1449,703Positive News
PGNY
Progyny
2.1108 of 5 stars
$23.18
+3.1%
$24.82
+7.1%
+10.0%$1.93B$1.17B40.67310

Related Companies and Tools


This page (NASDAQ:GRAL) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners